Finance

Lists
SNDX:NASDAQ
Syndax Pharmaceuticals Inc
US$ १६.९९
+०.५३%
(+०.०९०) 1D
US$ १७.७५
+४.४७% (+०.७६)
After hours
Closed: अक्टोबर ९, १६:००:०० GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SNDX...
Open
US$ १६.९१
High
US$ १७.४२
Low
US$ १६.७८
Mkt. cap
१.५२ अरब
Avg. vol.
१७.३० लाख
Volume
१४.५९ लाख
52-wk high
US$ २५.५९
52-wk low
US$ १३.००
EPS
-US$ २.५२
Beta
०.४३
Shares outstanding
८.९३ करोड
No. of employees
२९८
Open
US$ १६.९१
High
US$ १७.४२
Low
US$ १६.७८
Mkt. cap
१.५२ अरब
Avg. vol.
१७.३० लाख
Volume
१४.५९ लाख
52-wk high
US$ २५.५९
52-wk low
US$ १३.००
EPS
-US$ २.५२
Beta
०.४३
Shares outstanding
८.९३ करोड
No. of employees
२९८
News stories
From web sources and news partners
About Syndax Pharmaceuticals Inc
CEO-
Employees२९८
Founded२००५
Headquarters-
Sector-
Websitesyndax.com
Analyst ratings
Based on 10 analysts giving stock ratings to SNDX in the past 3 months
Strong buy
Buy
10
Hold
0
Sell
0
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for SNDX in the last 3 months.
Highest
Current US$ १६.९९
US$ ५७.०० (+२३५.४९%)
Average
US$ ३७.३३ (+११९.७२%)
Lowest
US$ २६.०० (+५३.०३%)
Analyst
Recommendation
Action
Price target
Projected
Date
Andres Y. Maldonado
H.C. Wainwright
Buy
Reiterated
US$ ३८.००
+१२३.७%
10/01/2026
Yigal Nochomovitz
Citi
Buy
Maintained
US$ ५७.००
+२३५.५%
09/29/2026
David Dai
UBS
Buy
Reiterated
US$ ३३.००
+९४.२%
08/21/2026
Stephen Willey
Stifel Nicolaus
Buy
Maintained
US$ ४०.००
+१३५.४%
08/14/2026
Anupam Rama
J.P. Morgan
Buy
Maintained
US$ ४०.००
+१३५.४%
08/11/2026
Jason Zemansky
Bank of America Securities
Buy
Maintained
US$ २६.००
+५३%
08/05/2026
Etzer Darout
Barclays
Buy
Maintained
US$ ३७.००
+११७.८%
08/05/2026
Phil Nadeau
TD Cowen
Buy
Maintained
-
-
08/04/2026
Bradley Canino
Guggenheim
Buy
Maintained
US$ ३१.००
+८२.५%
07/14/2026
Corinne Johnson
Goldman Sachs
Buy
Maintained
US$ ३४.००
+१००.१%
07/14/2026
Faisal Khurshid
Jefferies
Buy
Maintained
US$ ३७.००
+११७.८%
05/01/2026
Unknown Analyst
Jefferies
Buy
Maintained
US$ ४०.००
+१३५.४%
03/30/2026
Unknown Analyst
Mizuho Securities
Buy
Maintained
US$ ४३.००
+१५३.१%
03/30/2026
Salim Syed
Mizuho Securities
Buy
Maintained
US$ ४३.००
+१५३.१%
03/30/2026
Last report
२०२६ अगस्ट ४
Fiscal period
Q2 2026
-US$ ०.५५ / -US$ ०.४४
-२६.०१%miss
Revenue / Est. (USD)
७.२८ करोड / ७.९६ करोड
-८.५१%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
४.५९ करोड
६.८७ करोड
६.४९ करोड
७.२८ करोड
Cost of goods sold
५.८४ करोड
८.१३ करोड
६.१५ करोड
७.१२ करोड
Cost of revenue
५.८४ करोड
८.१३ करोड
६.१५ करोड
७.१२ करोड
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
४.४९ करोड
४.९९ करोड
३.७६ करोड
४.१५ करोड
Operating expense
४.४९ करोड
४.९९ करोड
३.७६ करोड
४.१५ करोड
Total operating expenses
१०.३३ करोड
१३.१३ करोड
९.९१ करोड
११.२८ करोड
Operating income
-५.७४ करोड
-६.२५ करोड
-३.४२ करोड
-४.०० करोड
Other non operating income
-२.७५ लाख
-२.०१ लाख
-१.८६ लाख
-४.३८ लाख
EBT including unusual items
-६.०७ करोड
-६.८० करोड
-४.२७ करोड
-४.९४ करोड
EBT excluding unusual items
-६.०७ करोड
-६.८० करोड
-४.२७ करोड
-४.९४ करोड
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-६.०७ करोड
-६.८० करोड
-४.२७ करोड
-४.९४ करोड
Net profit margin
-१३२.३६%
-९८.९६%
-६५.७९%
-६७.८२%
Earnings per share
-०.७०
-०.७८
-०.४८
-०.५५
Interest and investment income
५२.६९ लाख
४३.२८ लाख
३५.६१ लाख
३७.४६ लाख
Interest expense
-८२.८३ लाख
-९५.९३ लाख
-१.१८ करोड
-१.२७ करोड
Net interest expenses
-३०.१४ लाख
-५२.६५ लाख
-८२.८५ लाख
-८९.३० लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-५.७४ करोड
-६.२५ करोड
-३.४२ करोड
-४.०० करोड
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू